Introduction
Differentiated epithelial and endothelial cells have strong attachment requirements, presumably to prevent cellular vagrancy and consequent tissue disorganization. During transformation, cells lose such anchorage context and not only survive but also proliferate without attachment to solid matrix. Certain pathways downstream from integrins may influence detachment signals. Ectopic expression of integrin-linked kinase, TrkB, or oncogenic forms of Src and Ras have been shown to abrogate anoikis (Frisch and Francis, 1994; Frisch et al., 1996; Attwell et al., 2000; McFall et al., 2001; Douma et al., 2004) . In addition, during certain stages of development and tissue repair, normal cells also bypass anoikis in order to migrate, suggesting native regulation of endogenous proteins that control attachment sensation.
The adapter protein p66 Shc was recently found to localize to focal adhesions and permit attachment sensation by imposing RhoA-dependent tension across these integrin anchorage points, creating a mechanosensory test of anchorage . Upon detachment of cells from their underlying matrix, this p66-dependent tension test is met with load failure, initiating apoptosis. In contrast, the absence of p66 Shc allows both survival and proliferation of unanchored 293 cells. In this study, we test the relevance of p66
Shc to metastatic capacity and control of proliferation in both normal and transformed cells. Surprisingly, we find that p66
Shc functions to restrain Ras and allow its physiologic regulation. Upon loss of p66 Shc expression, endogenous Ras becomes hyperactivated and phenocopies oncogenic Ras, suppressing proliferation through retinoblastoma (pRB) in normal cells but allowing anchorage independence in vitro and aggressive metastasis of lung cancer cells in vivo.
Results

p66
Shc acts upstream of RhoA to control anoikis in normal and lung cancer cells The SHC gene encodes three proteins that differ in the length of the amino terminus (p46, p52 and p66). We examined Shc proteins in three highly metastatic cancer cells, the mouse Lewis lung carcinoma (LLC) and two lines of human small cell lung cancer (SCLC; H69 and H209) harvested from metastatic sites. In contrast to primary normal human bronchial epithelial (NHBE) cells, which express all three forms of Shc, the LLC, H69 and H209 cell lines lacked detectable p66 Shc ( Figure 1a ). Re-expression of p66
Shc through lentiviral transduction caused constitutive activation of RhoA in all three cell lines (Figure 1b) , consistent with the ability of p66
Shc to act upstream of RhoA in attachment sensing . Indeed, re-expression of p66
Shc restored anoikis in floating cultures of all three cancer cell lines, which was reversed by RhoA(N19) (Figure 1c) . Conversely, primary epithelial and endothelial cells (NHBE and human umbilical vein endothelial cells) express p66
Shc and display basal activation of RhoA. Knockdown of p66
Shc by lentiviral delivery of short hairpin RNA (shRNA) completely suppressed basal RhoA activity (Figure 1d ). NHBE cells, typical of normal epithelial cells, have intact anoikis mechanisms with significant cell death in floating culture for 16 h (Figure 1e ). Knockdown of p66
Shc or expression of RhoA(N19) significantly blocked detachment-induced cell death (Figure 1e) . A second small hairpin against p66 Shc (shRNA(2)) confirmed that p66
Shc is necessary for anoikis ( Figure 1f ). Thus, in both normal and malignant epithelium, p66 Shc or p66(S36E), using retroviral transduction with the PINCO plasmid that expresses green fluorescent protein (GFP; Grignani et al., 1998) . The S36E mutation lies within the N-terminal CH2 domain unique to the p66 Shc isoform, and abrogates its attachment-sensing function . As expected, LLC cells expressing p66 Shc had increased cell death following detachment but not while attached, whereas p66(S36E) had little effect (Figure 2a) . Expression of p66 Shc or p66(S36E) had no significant effect on the proliferation of adherent LLC cells (Figure 2b) , suggesting a specific effect on anoikis in these cells.
When injected into the tail vein of C57BL/6 mice, control LLC cells caused lethality in 18/19 mice by 45 days, with a median survival of 25 days (Figure 2c) . In all cases, death was accompanied by a heavy lung metastatic burden, easily identified by GFP-positive Shc and attachment sensing Z Ma et al nodules had completely lost expression of p66
Shc despite being GFP positive ( Figure 2g ). Because these LLC cells were not clonally selected, it is likely that the metastases in this animal represented a subclonal outgrowth of LLC cells, selected for their loss of p66 Shc . In further support of the specific effect of p66
Shc on metastatic capability, the mortality of mice injected with LLC cells expressing p66(S36E) resembled that of mice injected with control LLC cells, with 15/19 animals dying of lung metastases in 45 days for a median survival of 27 days. A representative sampling of metastatic nodules from this group showed no loss of presumably mutant p66 ( Figure 1g ). Thus, loss of metastatic capacity in vivo correlated accurately with anoikis in vitro and with expression of p66
Shc with an intact CH2 domain.
Absence of p66
Shc arrests proliferation through activation of pRB Because matrix attachment also permits proliferative signaling, we next asked whether loss of p66
Shc also influences cell growth. Despite their continued attachment to culture dishes, knockdown of p66
Shc effectively blocked proliferation of NHBE cells, suggesting that loss of attachment sensation may cause a default cell cycle arrest (Figure 3a) . In contrast, LLC and SCLC cells proliferate despite the absence of p66 Shc . Notably, B90% of SCLC tumors are known to lack functional pRB (Wistuba et al., 2001) , allowing for the possibility that pRB may normally enforce a proliferative arrest following the loss of p66 Shc , an effect lost without functional pRB. In support of this hypothesis, expression of the pocket-binding viral protein E7 by NHBE effectively reversed the growth arrest induced by p66 Shc knockdown, whereas the nonfunctional E7(D21-24) had no effect (Figure 3a) . In parallel, p66
Shc knockdown caused hypophosphorylation (activation) of endogenous pRB (Figure 3b ). The effect of p66
Shc knockdown on pRB phosphorylation and proliferation was confirmed with the second shRNA against p66 Shc (Figures 3b  and c) . We further found that LLC, H69 and H209 cells lacked significant pRB expression (Figure 3d ). Although expression of p66
Shc alone did not reduce proliferation in any of these tumor cell lines, pRB expression reduced proliferation to a variable degree (Figures 3e-g ). Strikingly, expression of p66
Shc reversed the growthsuppressive effect of pRB in all three cell lines. These data suggest that in both normal and transformed epithelium, p66
Shc acts upstream of pRB to suppress its function, allowing cell cycle progression. Thus, in the absence of p66 Shc and attachment sensing Z Ma et al cells, the absence of p66 Shc is tolerated because of the additional loss of pRB, which permits cell growth.
p66
Shc restrains K-Ras hyperactivation upstream from pRB The effect of p66
Shc on proliferation appears to be distinct from its effect on anoikis, which is RhoA dependent but pRB independent, as p66
Shc restores anoikis in SCLC and LLC cells without pRB (Figure 1c) . Because Ras potentially influences both pRB and RhoA, we next asked if Ras acts as a coordination point for both pathways. Notably, SCLC and LLC cells displayed high basal levels of Ras activation (Figure 4a) . In all three cell lines, Ras activation was quantitatively decreased by expression of p66 Shc , indicating suppression of Ras activity by p66
Shc independent of pRB. Specifically, p66 Shc suppressed K-Ras with no effect on N-Ras. In these cells, H-Ras was not expressed in significant levels (Figure 4b) . Conversely, in primary NHBE and human umbilical vein endothelial cells, basal Ras activity was low but became hyperactivated by p66
Shc knockdown (Figure 4c) . In NHBE cells, this effect was also specific for K-Ras and not H-Ras or N-Ras (Figure 4d) . Again, Shc restrains hyperactivation of K-Ras. We next asked if the hyperactivation of K-Ras due to loss of p66 Shc led to the acquisition of a constitutively active Ras-like state. In normal primary cells, endogenously controlled native Ras is transiently activated to suppress pRB function to allow cell cycle progression (Mittnacht et al., 1997; Peeper et al., 1997) . In contrast, expression of constitutively active oncogenic Ras mutants such as Ras(V12) in normal cells causes cell cycle arrest, an effect requiring intact pRB function (Phelps et al., 1988; Serrano et al., 1997) . Accordingly, suppression of basal Ras activity with Ras(N17) decreased NHBE cell proliferation at baseline (Figure 4f ). However, in the presence of Ras(N17), knockdown of p66
Shc no longer suppressed proliferation, and phosphorylation of pRB was partly restored (Figures 4f and g ). p66
Shc knockdown also induced the cyclin-dependent kinase 4 inhibitor p16
INK4A
, although Ras(N17) did not significantly block this induction (Figure 4g ), suggesting both Ras-dependent and Rasindependent effects of p66
Shc on pRB. These data indicate that loss of p66
Shc may indeed leave native Ras in a dysregulated hyperactive state, leading to pRBdependent proliferative arrest, comparable to the effects of oncogenic Ras mutations.
We further tested the effect of Ras deregulation on proliferation in the lung cancer cell lines. First, we noted that Ras(N17) did not suppress proliferation of either the LLC or SCLC cell lines, which display basal Ras hyperactivation but lack pRB (Figures 4h-j) . However, upon re-expression of pRB, proliferation decreased and was restored by Ras(N17) (Figures 4h-j) . These data confirm that Ras, rendered hyperactive by lack of p66 Shc , acts similarly to constitutively active oncogenic Ras in its ability to suppress proliferation through pRB, even in fully transformed cells. These data also highlight the importance of pRB loss in the development of SCLC, without which hyperactive Ras would be poorly tolerated.
p66
Shc restrains hyperactivation of Rac1 and deactivation of RhoA downstream from Ras Transformation triggered by oncogenic Ras requires Rac1 (Qiu et al., 1995) , which also mediates anchoragedependent proliferative signals (Mettouchi et al., 2001) . We therefore explored a potential role for Rac1 in the p66
Shc -Ras pathway. Similar to its effect on Ras, we found that re-expression of p66
Shc in LLC and SCLC cells reduced basal Rac1 activity; conversely, p66 Shc knockdown in primary NHBE and human umbilical vein endothelial cells caused robust activation of Rac1 (Figures 5a and b) . In NHBE cells, Rac1 hyperactivation was suppressed by Ras(N17), whereas Rac1(N17) had no effect on hyperactivation of Ras (Figures 5c  and d) , indicating activation of Rac1 downstream from Ras following loss of p66 Shc . In contrast, the activity of RhoA was suppressed by p66 Shc knockdown and restored by Ras(N17) and Rac1(N17) (Figure 5e ). Thus, loss of p66
Shc blocks RhoA downstream from constitutive activation of Ras and Rac1.
Next, we placed Rac1 and RhoA in the pathways leading to control of proliferation and anoikis downstream from Ras. In LLC and SCLC cells, Rac1(N17) reversed the pRB-induced suppression of proliferation to a similar extent as Ras(N17) (Figures 5f-h ). This finding suggests that hyperactive Ras suppresses growth in these malignant cells in the presence of pRB through Rac1. In contrast to Ras and Rac1, RhoA activity is suppressed in LLC and SCLC cells (Figure 1b) . However, restoration of RhoA activity with RhoA(V14) had no effect on pRB-induced suppression of proliferation (Figures 5f-h) . Therefore, hyperactive Ras signals bifurcate at Rac1 to suppress proliferation and anoikis through distinct pathways, with RhoA controlling anoikis and not proliferation in this context. Lastly, to confirm that RhoA-dependent anoikis requires Ras restraint by p66 Shc , we noted that suppression of Ras hyperactivation with Ras(N17) restored anoikis in floating cultures of LLC, H69 and H209 cells (Figures 5i-k) . Furthermore, re-expression of p66 Shc , which suppresses Ras (Figure 4a ), also restored anoikis; however, concomitant expression of Ras(V12) overrode this effect, blocking p66 Shc -induced anoikis in all three cell lines (Figures 5i-k) . These data confirm that the effects of p66 Shc on Ras restraint govern RhoAdependent anoikis.
Discussion
The model that emerges from this study suggests that p66
Shc serves as an important coordination point influencing Ras and pRB pathways (Figure 6 ). Given its role in initiating anchorage-sensing pathways , we speculate that p66
Shc normally lends attachment context to cell-fate decisions through these two pathways. Ras and pRB have complex functional interactions controlling proliferation and differentiation. Detailed genetic studies suggest that endogenous N-Ras and K-Ras interact with Rb1 loss in mice to suppress differentiation of pituitary tumors and enhance malignant transformation (Takahashi et al., 2004 (Takahashi et al., , 2006 . However, in these Rb1 heterozygotes, N-Ras but not K-ras appears to have an opposite role in the progression of C-cell adenomas to metastatic carcinomas (Takahashi et al., 2006) , suggesting tissue-and isoform-specific effects of Ras. Notably, these studies suggest that in the setting of tumorigenesis following loss of pRB, Ras influences differentiation rather than proliferation. Studies using oncogenic Ras to initiate tumorigenesis generally support the role of Ras in reversing differentiation. In this context, pRB acts as a tumor suppressor by irreversibly arresting proliferation in the face of constitutively active Ras (Lundberg et al., 2000) ; however, suppression of the pRB pathway allows oncogenic Ras to facilitate anchorage-independent growth in vitro and promote tumorigenesis in vivo despite low proliferation rates, indicating loss of differentiation as the primary effect of oncogenic Ras (Phelps et al., 1988; Ho et al., 2009 ). Shc acts primarily to disable anoikis rather than promote proliferation rates, again similar to the effects of oncogenic Ras on reversing differentiation. The loss of metastatic capacity upon re-expression of p66
Shc by LLC cells effectively demonstrates the biological significance of this effect. Given its parallel effects on restoring anoikis in SCLC cells, these results suggest that p66
Shc may act as an important metastasis suppressor.
An additional ramification of Ras deregulation may lie in the observation that oncogenic Ras mutations are rarely found in SCLC (Wistuba et al., 2001) . In the H69 and H209 cell lines, we demonstrate that K-Ras is constitutively hyperactivated in the absence of p66 Shc , leading to their characteristic anchorage-independent phenotype. Such basal hyperactivation would suggest that there would be little selective pressure favoring the outgrowth of cells harboring activating mutations of Ras. This interpretation is consistent with the lack of effect of oncogenic v-Ras on classic SCLC lines (Mabry et al., 1988) .
The mechanism by which p66 Shc restrains Ras and thus promotes RhoA activation remains unclear. p66
Shc is known to antagonize the proliferative effects of EGF, which work in part through p52
Shc and therefore suggests an antagonistic relationship between the two isoforms (Migliaccio et al., 1997; Okada et al., 1997) . The basis for the divergent effects of the two Shc 
H69
Cell death (fold control) Shc knocked down as indicated in NHBE cells, and active Rac1, Ras and RhoA were assessed by pulldown. (f-h) Dominant negatives Ras(N17) and Rac1(N17) and constitutively active RhoA(V14) were delivered by adenovirus; pRB was expressed by lentiviral delivery in LLC, H69 and H209 cells. pRB suppressed BrDU uptake (*Po0.001 from lacZ/vector control), whereas both Ras(N17) and Rac1(N17) restored proliferation above baseline ( w Po0.001 from lacZ/pRB). Active RhoA(V14) did not rescue proliferation from pRB. Mean ± s.e.m. of six determinations is shown. (i-k) LLC, H69 and H209 cells were grown in low attachment plates following transduction as indicated. DNA fragmentation was assessed 16 h later. Suppression of endogenous Ras with Ras(N17) caused death in floating cells for all three cell lines to levels comparable to those caused by p66
Shc expression (*Po0.001 from lacZ/vector control). In contrast, active Ras(V12) rescued all three cells from p66 Shc and attachment sensing Z Ma et al isoforms on EGF/EGFR signaling is thought to be related to competition for the Sos adapter Grb2, although one anticipated effect is activation of Rac1 at the expense of Ras (Khanday et al., 2006) , an effect that we did not find. Furthermore, although p66
Shc is felt to be a negative regulator of ERK, the direct effect of p66
Shc on Ras itself has not been studied. A more widely recognized effect of p66
Shc is its ability to initiate oxidative stress and cell death, through translocation to the mitochondrial inner membrane and redox cycling with cytochrome c (Giorgio et al., 2005) . However, we have previously shown that p66
Shc mutations that abrogate cytochrome c binding retain full capacity to initiate anoikis , consistent with its primary effect in conferring attachment context through regulation of Ras.
We conclude that p66 Shc normally restrains Ras from becoming hyperactivated with subsequent loss of RhoAdependent anoikis. As in the case of oncogenic Ras, pRB is activated as a downstream failsafe consequence following loss of p66 Shc expression, halting proliferation. In the evolution of highly metastatic tumors such as SCLC, the loss of RB1 may allow subsequent repression of p66
Shc with acquisition of metastatic capacity.
GTPase pulldown assays Active RhoA was assessed by pulldown using rhotekin-RBD-GST . Active Ras was assessed with pulldown using Raf-RBD-GST . Isoform-specific activation of Ras was assessed using the same pulldown technique followed by immunoblot with isoform-specific antibodies. Rac1 activity was assessed by pulldown using PBD-GST . Two-thirds of each sample was used for the pulldown assay and the remaining sample acetone-precipitated for assessment of total GTPase.
Cell culture
Phoenix-293 and Lewis lung carcinoma (LLC1) cells were obtained from American Type Culture Collection (Manassas, VA, USA). NHBE and human umbilical vein endothelial cells were from Lonza (Basel, Switzerland), and were routinely used at passages four and five. H209 and H69 SCLC cells were gifts of John Minna.
LLC metastasis
Retrovirus containing p66 Shc or p66(S36E) were used to infect LLC cells, which were subsequently treated with 1 mg/ml puromycin. Puromycin-resistant cells were then selected by cell sorting for GFP expression (FACS Vantage, BD). 5 Â 10 5 cells of each group in 100 ml saline were injected into the tail vein of 6-week-old female C57BL/6 mice. At 45 days following injection, surviving mice were killed. GFP-positive lung metastases were observed with the CRi MaestroTM imaging system (CRi, Woburn, MA, USA). Lungs were blotted, weighed and inflation fixed with formalin at 15 cm H 2 O pressure.
Cell death and proliferation assays Cells were plated on either cell culture-treated or lowattachment 24-well plates (Corning, Wilkes Barre, PA, USA) for 16 h. Cell death was assessed as DNA fragmentation using a cell death enzyme-linked immunosorbent assay (Roche, Basel, Switzerland). Absorbance was normalized for cell number. Proliferation was assessed using a 5-bromodeoxyuridine incorporation enzyme-linked immunosorbent assay (Roche), again normalizing for cell number.
Statistical analysis
Statistical analysis of cell death and proliferation end points was performed using analysis of variance with Tukey's post hoc RhoA Attachment Dependence Figure 6 Schematic indicating relationship of p66 Shc to proliferative and anoikis pathways through Ras and pRB, consistent with findings in both normal primary bronchial epithelium and malignant lung cancer lines studied. p66
Shc restrains Ras and Rac1 from hyperactivation. Signals bifurcate beyond Rac1 to control proliferation through pRB and attachment sensing through RhoA. Loss of anchorage context following loss of p66
Shc would allow survival while detached but suppress proliferation through pRB. The diagram includes possible Ras-independent effect of p66
Shc on pRB suppression. 
